Skip to content
About
Board of Directors
Acer Management
Key Strategic Consultants
Scientific Advisory Board
Careers
Product
Pipeline
OLPRUVA™ for MSUD
ACER-801 for iVMS
ACER-801 for ASD & PTSD
ACER-801 for Prostate Cancer
EDSIVO™ for vEDS
ACER-2820 for Infectious Diseases
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Induced Vasomotor Symptoms (iVMS)
Acute Stress Disorder (ASD) & Post-Traumatic Stress Disorder (PTSD)
Prostate Cancer
Vascular Ehlers-Danlos Syndrome (vEDS)
Infectious Diseases
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
About
Pipeline
Investor Relations
Publications
Contact Us
Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations
About
Pipeline
Investor Relations
Publications
Contact Us
ACER SEC
ACER SEC
Test
QUICK
NAV
MENU
MENU
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Product
Pipeline
Careers
OLPRUVA™ for MSUD
ACER-801 for iVMS
ACER-801 for Acute Stress Disorder (ASD) & Post-traumatic Stress Disorder (PTSD)
ACER-801 for Prostate Cancer
EDSIVO™ for vEDS
ACER-2820 for Infectious Diseases
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Induced Vasomotor Symptoms (iVMS)
Acute Stress Disorder and Post-Traumatic Stress Disorder
Prostate Cancer
Vascular Ehlers-Danlos Syndrome (vEDS)
Infectious Diseases
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
